Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Mannelli

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
European Journal of Endocrinology|February 11, 2017
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter studyMaria Vittoria Davi', Elisa Cosaro, Serena Piacentini, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 14, 2015
Functional and in silico assessment of MAX variants of unknown significanceIñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al.
Cancers|November 27, 2021
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in ItalyLetizia Canu, Soraya Puglisi, Paola Berchialla, et al.
Nature Genetics|April 22, 2014
Integrated genomic characterization of adrenocortical carcinomaGuillaume Assié, Eric Letouzé, Martin Fassnacht, et al.
Nature Genetics|June 21, 2011
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaIñaki Comino-Méndez, Francisco J Gracia-Aznárez, Francesca Schiavi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2019
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective StudySegolene Hescot, Maria Curras-Freixes, Timo Deutschbein, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2018
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patientsBruna Calsina, Maria Currás-Freixes, Alexandre Buffet, et al.
JAMA Oncology|July 12, 2019
Value of Molecular Classification for Prognostic Assessment of Adrenocortical CarcinomaGuillaume Assié, Anne Jouinot, Martin Fassnacht, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Human Molecular Genetics|February 19, 2013
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino-Méndez, Aguirre A de Cubas, Carmen Bernal, et al.
The Journal of Clinical Endocrinology and Metabolism|November 20, 2012
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacementVasileios Chortis, Angela E Taylor, Petra Schneider, et al.
European Journal of Endocrinology|February 11, 2017
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter studyMaria Vittoria Davi', Elisa Cosaro, Serena Piacentini, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 14, 2015
Functional and in silico assessment of MAX variants of unknown significanceIñaki Comino-Méndez, Luis J Leandro-García, Guillermo Montoya, et al.
Cancers|November 27, 2021
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in ItalyLetizia Canu, Soraya Puglisi, Paola Berchialla, et al.
Nature Genetics|April 22, 2014
Integrated genomic characterization of adrenocortical carcinomaGuillaume Assié, Eric Letouzé, Martin Fassnacht, et al.
Nature Genetics|June 21, 2011
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaIñaki Comino-Méndez, Francisco J Gracia-Aznárez, Francesca Schiavi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2019
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective StudySegolene Hescot, Maria Curras-Freixes, Timo Deutschbein, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 17, 2018
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patientsBruna Calsina, Maria Currás-Freixes, Alexandre Buffet, et al.
JAMA Oncology|July 12, 2019
Value of Molecular Classification for Prognostic Assessment of Adrenocortical CarcinomaGuillaume Assié, Anne Jouinot, Martin Fassnacht, et al.
Pageof 14